Long-term Survivors of Anaplastic Thyroid Cancer: A Genomic Predictive Model

Area of Science:

• Genomics
• Oncology
• Bioinformatics

Background:

• Anaplastic Thyroid Cancer (ATC) survival is possible for some patients, but genomic factors influencing outcomes are not well understood.
• Identifying genetic markers can improve risk stratification and treatment strategies for ATC.

Purpose of the Study:

• To develop a mathematical model for predicting mutation-based survival risk in Anaplastic Thyroid Cancer.
• To identify specific genes associated with aggressive ATC phenotypes.

Main Methods:

• Retrospective analysis of 204 ATC samples from the cBioPortal database.
• Development of a point-based risk model using multivariate analysis to identify prognostic genes.
• Validation of the model using a separate cohort and BRAF subanalysis.

Main Results:

• Fourteen genes were identified as risk factors for increased ATC progression.
• The developed risk model showed a C-index of 0.74, differentiating between aggressive and less aggressive patient cohorts.
• Significant differences in 1-year survival rates were observed between risk groups (0% vs. 32%).

Conclusions:

• The developed model effectively identifies mutated genes linked to the most aggressive forms of ATC.
• This tool can aid in preoperative risk assessment for patients undergoing surgery for curative intent.
• Further research into pathway enrichment in aggressive tumors may reveal therapeutic targets.